Volume 7, Issue 12: CFTR Modulators: Clinical Insights
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 7, Issue 12)
Target Audience
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Describe potential side effects that may occur with CFTR modulator treatment.
- Discuss which patients are candidates for CFTR modulators and what short- and long-term benefits might be seen.
- Summarize the potential disease modifying therapies in clinical development to treat cystic fibrosis.
John P. Clancy, MD
Professor, UC Department of
Pediatrics Gunnar
Esiason/Cincinnati Bell Chair
Research Director, Division of
Pulmonary Medicine Cincinnati
Children’s Hospital Medical Center
Cincinnati, Ohio
Professor, UC Department of
Pediatrics Gunnar
Esiason/Cincinnati Bell Chair
Research Director, Division of
Pulmonary Medicine Cincinnati
Children’s Hospital Medical Center
Cincinnati, Ohio
Available Credit
- 0.50 ANCC
- 0.50 Attendance